nodes	percent_of_prediction	percent_of_DWPC	metapath
Amsacrine—TOP2A—Menadione—Thalidomide—leprosy	0.0501	1	CbGdCrCtD
Amsacrine—Proteinuria—Dapsone—leprosy	0.0424	0.0447	CcSEcCtD
Amsacrine—Protein urine present—Dapsone—leprosy	0.0418	0.044	CcSEcCtD
Amsacrine—Febrile neutropenia—Thalidomide—leprosy	0.0317	0.0334	CcSEcCtD
Amsacrine—Hypomagnesaemia—Thalidomide—leprosy	0.03	0.0316	CcSEcCtD
Amsacrine—Proteinuria—Thalidomide—leprosy	0.0217	0.0229	CcSEcCtD
Amsacrine—Protein urine present—Thalidomide—leprosy	0.0214	0.0225	CcSEcCtD
Amsacrine—Hyperuricaemia—Thalidomide—leprosy	0.0206	0.0217	CcSEcCtD
Amsacrine—Creatinine increased—Thalidomide—leprosy	0.02	0.0211	CcSEcCtD
Amsacrine—Blood uric acid increased—Thalidomide—leprosy	0.0194	0.0205	CcSEcCtD
Amsacrine—Phosphatase alkaline increased—Thalidomide—leprosy	0.0191	0.0201	CcSEcCtD
Amsacrine—Blood urea increased—Thalidomide—leprosy	0.018	0.019	CcSEcCtD
Amsacrine—Aplastic anaemia—Thalidomide—leprosy	0.0179	0.0189	CcSEcCtD
Amsacrine—Sepsis—Thalidomide—leprosy	0.0166	0.0174	CcSEcCtD
Amsacrine—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.0159	0.0168	CcSEcCtD
Amsacrine—Vascular purpura—Thalidomide—leprosy	0.0155	0.0163	CcSEcCtD
Amsacrine—Vision blurred—Dapsone—leprosy	0.0154	0.0162	CcSEcCtD
Amsacrine—Cardiac failure congestive—Thalidomide—leprosy	0.0153	0.0161	CcSEcCtD
Amsacrine—Atrial fibrillation—Thalidomide—leprosy	0.0146	0.0154	CcSEcCtD
Amsacrine—Purpura—Thalidomide—leprosy	0.0144	0.0151	CcSEcCtD
Amsacrine—Lethargy—Thalidomide—leprosy	0.0141	0.0149	CcSEcCtD
Amsacrine—Affect lability—Thalidomide—leprosy	0.0136	0.0144	CcSEcCtD
Amsacrine—Mood swings—Thalidomide—leprosy	0.0131	0.0138	CcSEcCtD
Amsacrine—Tachycardia—Dapsone—leprosy	0.013	0.0137	CcSEcCtD
Amsacrine—Blood creatinine increased—Thalidomide—leprosy	0.013	0.0137	CcSEcCtD
Amsacrine—Aspartate aminotransferase increased—Thalidomide—leprosy	0.0125	0.0131	CcSEcCtD
Amsacrine—Dysphagia—Thalidomide—leprosy	0.012	0.0126	CcSEcCtD
Amsacrine—Pancytopenia—Thalidomide—leprosy	0.0114	0.012	CcSEcCtD
Amsacrine—Weight increased—Thalidomide—leprosy	0.0109	0.0115	CcSEcCtD
Amsacrine—Gastrointestinal pain—Dapsone—leprosy	0.0109	0.0114	CcSEcCtD
Amsacrine—Weight decreased—Thalidomide—leprosy	0.0108	0.0114	CcSEcCtD
Amsacrine—Infestation NOS—Thalidomide—leprosy	0.0107	0.0112	CcSEcCtD
Amsacrine—Infestation—Thalidomide—leprosy	0.0107	0.0112	CcSEcCtD
Amsacrine—Abdominal pain—Dapsone—leprosy	0.0105	0.0111	CcSEcCtD
Amsacrine—Body temperature increased—Dapsone—leprosy	0.0105	0.0111	CcSEcCtD
Amsacrine—Renal failure—Thalidomide—leprosy	0.0105	0.011	CcSEcCtD
Amsacrine—Stomatitis—Thalidomide—leprosy	0.0104	0.011	CcSEcCtD
Amsacrine—Haematuria—Thalidomide—leprosy	0.0102	0.0107	CcSEcCtD
Amsacrine—Agranulocytosis—Thalidomide—leprosy	0.00996	0.0105	CcSEcCtD
Amsacrine—Bradycardia—Thalidomide—leprosy	0.00976	0.0103	CcSEcCtD
Amsacrine—Hepatitis—Thalidomide—leprosy	0.00958	0.0101	CcSEcCtD
Amsacrine—Hypoaesthesia—Thalidomide—leprosy	0.00953	0.01	CcSEcCtD
Amsacrine—Urinary tract disorder—Thalidomide—leprosy	0.00946	0.00996	CcSEcCtD
Amsacrine—Urethral disorder—Thalidomide—leprosy	0.00939	0.00989	CcSEcCtD
Amsacrine—Cardiac disorder—Thalidomide—leprosy	0.00889	0.00936	CcSEcCtD
Amsacrine—Angiopathy—Thalidomide—leprosy	0.00869	0.00915	CcSEcCtD
Amsacrine—Mediastinal disorder—Thalidomide—leprosy	0.00864	0.00909	CcSEcCtD
Amsacrine—Arrhythmia—Thalidomide—leprosy	0.00856	0.00901	CcSEcCtD
Amsacrine—Alopecia—Thalidomide—leprosy	0.00847	0.00891	CcSEcCtD
Amsacrine—Vomiting—Dapsone—leprosy	0.00846	0.0089	CcSEcCtD
Amsacrine—Mental disorder—Thalidomide—leprosy	0.0084	0.00884	CcSEcCtD
Amsacrine—Malnutrition—Thalidomide—leprosy	0.00834	0.00878	CcSEcCtD
Amsacrine—Headache—Dapsone—leprosy	0.00833	0.00877	CcSEcCtD
Amsacrine—Nausea—Dapsone—leprosy	0.0079	0.00832	CcSEcCtD
Amsacrine—Vision blurred—Thalidomide—leprosy	0.00786	0.00828	CcSEcCtD
Amsacrine—Anaemia—Thalidomide—leprosy	0.00771	0.00812	CcSEcCtD
Amsacrine—Leukopenia—Thalidomide—leprosy	0.00747	0.00786	CcSEcCtD
Amsacrine—Convulsion—Thalidomide—leprosy	0.00723	0.00761	CcSEcCtD
Amsacrine—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00705	0.00743	CcSEcCtD
Amsacrine—Confusional state—Thalidomide—leprosy	0.00686	0.00723	CcSEcCtD
Amsacrine—Infection—Thalidomide—leprosy	0.00676	0.00712	CcSEcCtD
Amsacrine—Thrombocytopenia—Thalidomide—leprosy	0.00667	0.00702	CcSEcCtD
Amsacrine—Tachycardia—Thalidomide—leprosy	0.00664	0.007	CcSEcCtD
Amsacrine—Skin disorder—Thalidomide—leprosy	0.00661	0.00696	CcSEcCtD
Amsacrine—Anorexia—Thalidomide—leprosy	0.00649	0.00683	CcSEcCtD
Amsacrine—Hypotension—Thalidomide—leprosy	0.00636	0.0067	CcSEcCtD
Amsacrine—Paraesthesia—Thalidomide—leprosy	0.00611	0.00644	CcSEcCtD
Amsacrine—Dyspnoea—Thalidomide—leprosy	0.00607	0.00639	CcSEcCtD
Amsacrine—Decreased appetite—Thalidomide—leprosy	0.00592	0.00623	CcSEcCtD
Amsacrine—Gastrointestinal disorder—Thalidomide—leprosy	0.00588	0.00619	CcSEcCtD
Amsacrine—Fatigue—Thalidomide—leprosy	0.00587	0.00618	CcSEcCtD
Amsacrine—Pain—Thalidomide—leprosy	0.00582	0.00613	CcSEcCtD
Amsacrine—Feeling abnormal—Thalidomide—leprosy	0.00561	0.00591	CcSEcCtD
Amsacrine—Gastrointestinal pain—Thalidomide—leprosy	0.00557	0.00586	CcSEcCtD
Amsacrine—Urticaria—Thalidomide—leprosy	0.00541	0.00569	CcSEcCtD
Amsacrine—Body temperature increased—Thalidomide—leprosy	0.00538	0.00567	CcSEcCtD
Amsacrine—Abdominal pain—Thalidomide—leprosy	0.00538	0.00567	CcSEcCtD
Amsacrine—Hypersensitivity—Thalidomide—leprosy	0.00502	0.00528	CcSEcCtD
Amsacrine—Asthenia—Thalidomide—leprosy	0.00488	0.00514	CcSEcCtD
Amsacrine—Diarrhoea—Thalidomide—leprosy	0.00466	0.0049	CcSEcCtD
Amsacrine—Dizziness—Thalidomide—leprosy	0.0045	0.00474	CcSEcCtD
Amsacrine—Vomiting—Thalidomide—leprosy	0.00433	0.00456	CcSEcCtD
Amsacrine—Rash—Thalidomide—leprosy	0.00429	0.00452	CcSEcCtD
Amsacrine—Dermatitis—Thalidomide—leprosy	0.00429	0.00451	CcSEcCtD
Amsacrine—Headache—Thalidomide—leprosy	0.00427	0.00449	CcSEcCtD
Amsacrine—Nausea—Thalidomide—leprosy	0.00404	0.00426	CcSEcCtD
